Home » Topics » Science » New compound

New compound
RSS

Tanabe selects ellipticine derivative for further development

Feb. 11, 1997

Potent gpIIb/IIIa antagonist synthesized using combinatorial techniques

Feb. 11, 1997

Potential anticonvulsant described by CoCensys

Feb. 7, 1997

Promising new imaging agent for CNS disorders

Feb. 7, 1997

Lilly/Novo Nordisk discover candidate for IBS

Feb. 6, 1997

Preliminary efficacy and safety data for an HIV therapeutic vaccine

Feb. 3, 1997

Ganciclovir prodrug shows potential for treatment of CMV retinitis

Feb. 3, 1997

British scientists describe novel therapeutic approach to HIV

Feb. 3, 1997

PMPA prodrug selected as clinical candidate

Feb. 3, 1997

Anti-HIV agent that targets NCp7 zing fingers

Feb. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...